Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1Lymphoid 1Genitourinary 1

Conditions

Myelodysplastic Syndromes 750Leukemia, Myeloid, Acute 635Leukemia 476Leukemia, Myelogenous, Chronic, BCR-ABL Positive 470Precursor Cell Lymphoblastic Leukemia-Lymphoma 409Myeloproliferative Disorders 339Lymphoma, Non-Hodgkin 271Leukemia, Myelomonocytic, Chronic 270Leukemia, Lymphocytic, Chronic, B-Cell 264Multiple Myeloma 259Hodgkin Disease 249Primary Myelofibrosis 230Leukemia, Myeloid, Chronic-Phase 217Lymphoma 203Blast Crisis 195Leukemia, Myeloid, Accelerated Phase 182Lymphoma, Mantle-Cell 168Lymphoma, Follicular 168Burkitt Lymphoma 166Lymphoma, Large B-Cell, Diffuse 162Lymphoma, B-Cell, Marginal Zone 151Congenital Abnormalities 148Polycythemia Vera 144Lymphoma, Large-Cell, Immunoblastic 141Anemia, Refractory, with Excess of Blasts 131Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 128Myelodysplastic-Myeloproliferative Diseases 126Neoplasms, Plasma Cell 117Thrombocythemia, Essential 114Lymphoma, T-Cell, Cutaneous 99

Interventions

Sodium Chloride 1BNT162 Vaccine 12019-nCoV Vaccine mRNA-1273 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Severe Acute Respiratory Syndrome × Myeloid × Clear all
NCT04761822 2025-08-12

SARS

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Completed
746 enrolled 28 charts
Myeloid

COVID-19, Hypersensitivity, Mastocytosis, Severe Acute Respiratory Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡